Posted by DNA Anabolics on 22nd Jan 2015
Oral Growth Hormone
Looking for a potent GH release that doesn’t involve needles and frustrating timing schedules? Ibutamoren (mk-677) may just fit the bill…
People
have always been a huge fan of Ipamorelin and CJC1295 (modified GRF
1-29) when it comes to increasing Growth Hormone levels. But those two
peptides require injections, and to really see benefits, you have to
inject it multiple times a day, and plan your meals out accordingly (you
want to be fairly fasted before using these, and then wait for at least
30 minutes before eating afterwards). So for those of you who don’t
want to jack with all that, and want a continuous, 24 hour increase in
GH, IGF-1 and IGF-BP3, then Ibutamoren, an orally active GH secretagogue may be just the ticket.
The
benefits of Growth Hormone on metabolism and lean body mass are
undeniable. I also go to great lengths pointing out that I don’t think
GH is much of a muscle builder per se, and that its ultimate benefit
comes down to controlling, or rather off-setting, the detrimental
effects of insulin on body composition, when it comes to excessive fat
gain. Insulin and IGF-1 are amazing at increasing protein synthesis, no
doubt, but the real benefits after extended trials of anything that
increases GH levels seem to come more in the way of increased leanness,
and decreased fat storage.
For
many, the use of HGH is not only too costly, but is not a good route to
go if overall health and longevity is of utmost importance. HGH,
injected exogenously, can create a really awesome environment for body
transformation, but with that comes the price of shutting down the HPA
production of natural pulses, which interferes with an overall healthier
body, for lack of a more scientific term. HGH is great at doing what it
does, but leaving it “on” for 8 hours post injection, can lead to
insulin resistance and water retention imbalances that ultimately take
their toll on the body, especially if someone is using large doses. GH
is not supposed to be a 24 hour ON button. It is supposed to peak and
drop, along with other hormones, to create the perfect environment for
long-term health and anti-aging benefits.
Enter
the injectable GH releasers such as Ipamorelin and GRF. These are very,
very good at getting the job done when it comes to increasing the
body’s own production of Growth Hormone. The biggest problem, though, is
that to really take advantage of the benefits, and to fully utilize the
peaks, a person would have to inject multiple times a day, and plan out
their diet accordingly (too much food in the gut will dampen the
release and peak of the GH).
But
with an orally active version like Ibutamoren, a single dose can
increase benefits throughout the entire day, without the need for
carrying around needles, watching your diet before and after injections,
and all that crap that goes with playing with GH releasers.
Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.
To assess the effects of prolonged administration of a novel analog of GH-releasing peptide (MK-677),
nine healthy young men participated in a randomized, double blind,
three-period cross-over comparison of orally administered placebo and 5-
and 25-mg doses of MK-677.
Each period involved bedtime administration of the drug for 7
consecutive days. At the end of each period, plasma levels of
insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3)
were measured at 0745 h, and 24-h profiles of plasma GH and cortisol
were obtained at 15-min intervals together with the 24-h urinary
excretion of free cortisol. Profiles of plasma free cortisol were
calculated at hourly intervals. The amounts of GH secreted were similar
in all three conditions, but GH pulse frequency was increased with both
dosages of the drug, primarily because of an increase in the number of
low amplitude pulses. Plasma IGF-I levels were increased in a
dose-dependent manner, whereas IGFBP-3 levels were increased only with
the highest dosage. There was a positive relationship between GH pulse
frequency and IGF-I increase. Except for an advance in the nocturnal
nadir and in the morning elevation, MK-677
had no effect on cortisol profiles. In particular, 24-h mean levels of
plasma total and free cortisol and urinary excretion of free cortisol
were similar under all conditions. The present data suggest that the use
of MK-677 for
the treatment of relative somatotropic deficiency, particularly in
older adults compromised by such deficiency, deserves further
investigation.
And a quick
note about the cortisol effects… A lot of these peptides increase
Cortisol, which is definitely not wanted during the peak of GH release,
if physical transformation is a goal. Many of these also increase
Prolactin, which can cause a lot of other side-effects. So an orally
active GH releaser that doesn’t increase Cortisol is definitely going to
be a game changer.
Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure
We conclude that 2-month treatment with MK-677
in healthy obese males caused a sustained increase in serum levels of
GH, IGF-I, and IGF-binding protein-3. The effects on cortisol secretion
were transient. Changes in body composition and energy expenditure were
of an anabolic nature, with a sustained increase in fat-free mass and a
transient increase in basal metabolic rate. Further studies are needed
to evaluate whether a higher dose of MK-677 or a more prolonged treatment period can promote a reduction in body fat.
Another
quick point. IGF-BP3 increases are a good thing. In some instances, we
see a binding protein and think of SHBG, Sex Hormone Binding Globulin,
which arguably makes Testosterone less effective. In this instance,
however, the binding protien IGF-BP3 is needed to carry the IGF-1 into
the cell and activate the receptor. So anything that increases IGF-1 AND
also increases BP3 is a definite benefit.